Intel's poor EMIB-T packaging yields threaten its plans for next year. Per a confidential source, yields are very poor, and EMIB-T may now slip into the following year. The 14A PDK 0.9 matters more for the long term. Intel remains a very strong long-term bull case because yields should improve, though setbacks can arise along the way; whether to avoid this near-term risk is a personal judgment. x.com  x.com  x.com  x.com  x.com  x.com 

Reported talks between SK hynix and Intel to make memory chips in the US are another strong data point for Intel Foundry, though nothing is signed. After multiple leaks of SK hynix looking at EMIB, big players are clearly treating Intel as a real alternative for advanced packaging. A deal would move EMIB from a backup option to core AI infrastructure, offloading packaging bottlenecks to US soil while undercutting TSMC on cost. Volume is not expected before 2027 or 2028. x.com 

Intel's advanced packaging story is already priced in; the stock got there a little too fast. EMIB and EMIB-T are legit, and the foundry pivot gives Intel a real narrative, but the market has moved ahead of it. x.com 

Intel's EMIB-T packaging could reaccelerate now that the root causes of substrate yields around 45-50% have been identified. Momentum for EMIB-T is rising for Google's TPU v10, supporting the mid- to long-term positive view despite the v9 timing slip. x.com 

Intel's EMIB packaging is ramping as advanced packaging becomes the next chokepoint after HBM. EMIB substrate yields reportedly rose from ~30% in 2Q26 to ~45%, with targets of 50% by 4Q26 and 60% by 1Q27. Google is expected to adopt EMIB-T in 2027 and AWS is testing it. CEO Lip-Bu Tan says Intel has to prepay substrate suppliers to secure capacity. CoWoS capacity is set to grow about 20x from 2023 to 370k wpm by 2028, more than TSMC can carry alone. x.com 

Intel looks a tad overvalued near $100, so it is not a buy right now, even though its fundamentals are strong. It is state-backed, demand is so high that lower-grade chips are sold rather than discarded, and its downstream stack, including EMIB packaging, is the strongest in about a decade, possibly outpacing its foundry business per Morgan Stanley reporting. x.com 

Intel's near-term growth is constrained by a Kiryat Gat factory blast and memory-driven PC weakness. The weak Q4 outlook calls for answers: the blast looks set to cut roughly $300 million of revenue in Q4 and could have a similar impact in Q1, limiting data-center growth. Fab ownership gives Intel pricing power and enterprise demand is strong; external foundry customers would add another tailwind if won. CEO Lip-Bu Tan said Nova Lake will allow Intel to take back share. x.com  x.com  x.com  x.com  … Show more

SK hynix's exceptional margins and contracted capacity underpin a bullish outlook despite shares sitting around half their June high. Q3 operating margin reached 80%, up from 47% a year ago; long-term deals with 14 customers cover over half of 2027-28 capacity, and management expects demand to exceed supply through 2030. x.com 

Intel's high valuation is hard to justify while its foundry turnaround remains unproven. At about 59x forward earnings, nearly three times TSMC's 19x, Intel has slower projected revenue growth; its foundry lost $2.09 billion in Q2 2026, while TSMC's Q3 operating margin was 58.7%. A politician's stock purchase alone does not make Intel a buy. x.com  x.com 

SK hynix's record earnings and five-year volume and spec agreements make its valuation look too low. Quarterly revenue reached KRW104.62T, up 32%, and operating profit hit $63B against a $785B market cap, below AMD's and less than half Tesla's. Its planned KRW100T (~$75B) shareholder return would be one of the world's largest, signaling conviction and unusual demand visibility. AI-inference 3D DRAM is coming by 2030; a reasonable valuation is all that is sought. x.com  x.com  x.com  x.com  x.com  … Show more